Quantinno Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.63M | Buy |
39,436
+28,359
| +256% | +$6.2M | 0.04% | 591 |
|
|
2025
Q1 | $2.48M | Buy |
11,077
+4,942
| +81% | +$1.11M | 0.02% | 910 |
|
|
2024
Q4 | $2.01M | Buy |
6,135
+2,297
| +60% | +$752K | 0.02% | 847 |
|
|
2024
Q3 | $1.15M | Buy |
3,838
+1,573
| +69% | +$472K | 0.02% | 906 |
|
|
2024
Q2 | $746K | Buy |
2,265
+344
| +18% | +$113K | 0.01% | 910 |
|
|
2024
Q1 | $760K | Buy |
1,921
+249
| +15% | +$98.5K | 0.02% | 827 |
|
|
2023
Q4 | $589K | Sell |
1,672
-252
| -13% | -$88.8K | 0.02% | 775 |
|
|
2023
Q3 | $722K | Buy |
1,924
+508
| +36% | +$191K | 0.03% | 613 |
|
|
2023
Q2 | $542K | Buy |
1,416
+145
| +11% | +$55.5K | 0.03% | 612 |
|
|
2023
Q1 | $440K | Sell |
1,271
-79
| -6% | -$27.3K | 0.03% | 625 |
|
|
2022
Q4 | $318K | Buy |
1,350
+485
| +56% | +$114K | 0.02% | 669 |
|
|
2022
Q3 | $213K | Buy |
865
+116
| +15% | +$28.6K | 0.03% | 564 |
|
|
2022
Q2 | $226K | Sell |
749
-860
| -53% | -$259K | 0.03% | 537 |
|
|
2022
Q1 | $661K | Buy |
1,609
+981
| +156% | +$403K | 0.1% | 248 |
|
|
2021
Q4 | $295K | Sell |
628
-815
| -56% | -$383K | 0.05% | 410 |
|
|
2021
Q3 | $613K | Buy |
1,443
+13
| +0.9% | +$5.52K | 0.68% | 22 |
|
|
2021
Q2 | $514K | Hold |
1,430
| – | – | 0.58% | 49 |
|
|
2021
Q1 | $403K | Sell |
1,430
-539
| -27% | -$152K | 0.44% | 96 |
|
|
2020
Q4 | $558K | Hold |
1,969
| – | – | 0.43% | 52 |
|
|
2020
Q3 | $541K | Sell |
1,969
-519
| -21% | -$143K | 0.36% | 90 |
|
|
2020
Q2 | $565K | Sell |
2,488
-1,516
| -38% | -$344K | 0.56% | 6 |
|
|
2020
Q1 | $610K | Sell |
4,004
-447
| -10% | -$68.1K | 0.38% | 77 |
|
|
2019
Q4 | $669K | Hold |
4,451
| – | – | 0.42% | 37 |
|
|
2019
Q3 | $631K | Sell |
4,451
-290
| -6% | -$41.1K | 0.43% | 30 |
|
|
2019
Q2 | $593K | Buy |
4,741
+2,678
| +130% | +$335K | 0.35% | 63 |
|
|
2019
Q1 | $227K | Sell |
2,063
-448
| -18% | -$49.3K | 0.15% | 323 |
|
|
2018
Q4 | $246K | Buy |
+2,511
| New | +$246K | 0.2% | 268 |
|